118th Congress Health
H.R. 71: Medical Innovation Acceleration Act of 2023
Introduced
- Introduced (completed)
- Passed House (not reached)
- Passed Senate (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Who scored on this bill
No member has earned points from it yet.
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by Andy Biggs
- H.J.Res. 1: Proposing an amendment to the Constitution of the United States to require that the Supreme Court of the United States be composed of nine justices.
- H.R. 8466: TRUE Accountability Act
- H.R. 8365: Monitor Accountability Act
- H.J.Res. 139: Proposing an amendment to the Constitution of the United States requiring a balanced budget for the Federal Government.
- H.R. 6732: Coercion and Sexual Abuse Free Environment Act
- H.R. 5172: Strong Sentences for Safer D.C. Streets Act of 2025
History
- Introduced in the House by Andy Biggs.
Show the full action history (3 actions)
- Introduced in House
- Referred to the Subcommittee on Health.
- Referred to the House Committee on Energy and Commerce.